Indian Patent Office rejects J&J’s application for paediatric formulation of lifesaving TB drug July 17, 2024 The Indian Patent Office has rejected the US pharmaceutical corporation Johnson & Johnson’s (J&J) application for a patent on the paediatric formulation of World Health Organization (WHO)-recommended TB drug... Trending Air pollution spikes inflammation in patients with heart disease: Study Nanoparticle emissions from transport major health risk in Delhi: Study Important to ensure medicines, medical products produced in India are of highest quality: Mandaviya Latest Air pollution spikes inflammation in patients with heart disease: Study Health ministry writes to all states on alarming air pollution, fire incidents ‘Antimicrobial Resistance a global health threat’ ICMR starts first in-human clinical trials for Zika vaccine
